title: [Mammography screening in Germany].
abstract: Available data suggest that early detection of breast cancer by mammography screening can reduce mortality by about 25%. Intensified monitoring of women with a family history of breast cancer and regular general screening have recently been introduced in Germany. The screening program is expected to be fully established by 2008. Following its successful introduction (participation rates between 65 and 80%), the German screening program will be conducted and evaluated in accordance with the European guidelines. At least in the screening trials that were conducted prior to the now established screening program the quality criteria were more than fulfilled (e.g. cancer detection rate in Bremen 8.7, Wiesbaden 9.4, Weser-Ems region 8.3/1000). Additional parameters that can be taken into account for quality assurance are the overdiagnosis bias, lead time bias, length bias and selection bias. Moreover, there are some factors that are specific to the German program compared with the breast cancer screening programs already established in other countries. One of these is the intensified screening program for high-risk women (ca. 5% of all carcinomas) and as a result fewer women with an increased genetic risk of breast cancer will be represented in the general screening program. The German screening program involves only a few university centers and hospital-based physicians, which may have adverse effects on research and development as well as mammography training in the future. Therefore, the screening program should also provide for the investigation of new techniques or emerging techniques (e.g. CAD systems in screening mammography) in the future.
authors.affiliation: Institut für Radiologie, Charité-Universitätsmedizin Berlin, Berlin, Deutschland.
authors.forename: S
authors.initials: S
authors.lastname: Diekmann
authors.forename: F
authors.initials: F
authors.lastname: Diekmann
mesh_terms: D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000000981:diagnostic imaging* / Q000191:economics / Q000235:genetics / Q000401:mortality; D003362:Cost-Benefit Analysis; D003431:Cross-Cultural Comparison; D042241:Early Diagnosis; D005260:Female; D005858:Germany; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000191:economics; D008327:Mammography / Q000009:adverse effects / Q000191:economics / Q000592:standards*; D008403:Mass Screening / Q000191:economics / Q000592:standards*; D008875:Middle Aged; D009381:Neoplasms, Radiation-Induced / Q000191:economics / Q000209:etiology; D011237:Predictive Value of Tests; D011785:Quality Assurance, Health Care / Q000592:standards*; D011829:Radiation Dosage; D018570:Risk Assessment; D012307:Risk Factors; D015996:Survival Rate